- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02577432
Two Syringe Spinal Anesthesia Technique for Cesarean Section: A Simple Way to Achieve More Satisfactory Block and Less Hypotension
Two Syringe Spinal Anesthesia Technique for Cesarean Section: A Controlled Randomized Study of a Simple Way to Achieve More Satisfactory Block and Less Hypotension
Background: Poor spinal anaesthesia block is common and is difficult to manage; so a technique to minimize its incidence is advisable. Hypotension is the commonest problem with spinal anesthesia. Multiple trials to prevent or combat hypotension using positional changes, fluid therapy and the use of vasopressors were tried. However, the drug choice and mode of administration as either bolus or infusion is still a matter of debate.
Objectives: To compare the outcome of spinal injection of hyperbaric bupivacaine and fentanyl separately to standard injection of mixed fentanyl with hyperbaric bupivacaine.
Design: A randomized, controlled clinical trial.
Setting: Single medical center from 5/2013 to 10/2014.
Patients & Methods: 124 parturient scheduled for elective cesarean section (CS) were randomly allocated into two groups, each 62 parturient: Group M received spinal anesthesia using 10 mg bupivacaine 0.5% premixed with 25 µg fentanyl in the same syringe and Group S received 25 µg fentanyl in one syringe and 10 mg bupivacaine 0.5% without barbotage in a second syringe. Intravenous fluid co-load with 15 ml/kg warm lactated ringer solution was started as fast drip during, and continued after spinal anesthesia.
Patients were monitored for hemodynamic parameters, time of sensory onset and height of maximum sensory block, lower limb motor blockade was scored using modified Bromage scale and the frequency of side effects.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parturient at full term.
- Must be elective cesarean section.
- Must be uncomplicated pregnancy
Exclusion Criteria:
- Body weight <50 kg or >90 kg
- Height ˂150 cm or >170 cm.
- Pre-eclampsia.
- Any major systemic disease.
- Contraindication to regional anesthesia.
- Allergy to used medications.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: (S) separate.
fentanyl and hyperbaric bupivacaine (sequentially)
|
Give 25 micro grams fentanyl intrathecal with one syringe.
Then immediately give 10 mg hyperbaric bupivacaine intrathecally with an other syringe.
Mix 25 micro grams fentanyl with 10 mg hyperbaric bupivacaine in one syringe.
Give them intrathecally.
Give 25 micro grams fentanyl intrathecal with one syringe.
Then immediately give 10 mg hyperbaric bupivacaine intrathecally with an other syringe.
|
Active Comparator: (M) mixed
fentanyl and hyperbaric bupivacaine.(mixed)
|
Give 25 micro grams fentanyl intrathecal with one syringe.
Then immediately give 10 mg hyperbaric bupivacaine intrathecally with an other syringe.
Mix 25 micro grams fentanyl with 10 mg hyperbaric bupivacaine in one syringe.
Give them intrathecally.
Mix 25 micro grams fentanyl with 10 mg hyperbaric bupivacaine in one syringe.
Give them intrathecally.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of parturients needed more analgesics (unsatisfactory block) using Ochsner Health System.
Time Frame: intraoperative
|
intraoperative
|
incidence of hypotension
Time Frame: intraoperative
|
intraoperative
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Amr A Keera, MD, Dr. Benha Faculty of Medicine
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Hypotension
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Anesthetics, Local
- Fentanyl
- Bupivacaine
Other Study ID Numbers
- 01/REC/2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Virginia Commonwealth UniversityRecruitingCesarean SectionUnited States
-
University Tunis El ManarCompleted
-
Federico II UniversityCompletedCesarean SectionItaly
-
Virginia Commonwealth UniversityCompletedCesarean SectionUnited States
-
University of CalgaryCompleted
-
Hallym University Kangnam Sacred Heart HospitalCompletedCesarean SectionKorea, Republic of
Clinical Trials on fentanyl
-
University of Maryland, BaltimoreFood and Drug Administration (FDA)CompletedPeer Review, ResearchUnited States
-
Alexza Pharmaceuticals, Inc.Completed
-
University of Maryland, BaltimoreFood and Drug Administration (FDA)Completed
-
University of Texas Southwestern Medical CenterCompletedPregnancyUnited States
-
Samuel Lunenfeld Research Institute, Mount Sinai...Terminated
-
University of PatrasUnknownStillborn Caesarean SectionGreece
-
Janssen Research & Development, LLCCompleted
-
Johns Hopkins UniversityCompletedIntracranial SurgeryUnited States
-
Ente Ospedaliero Cantonale, BellinzonaNot yet recruiting